{
    "clinical_study": {
        "@rank": "6653", 
        "arm_group": {
            "arm_group_label": "RoActemra/Actemra", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "This open-label study will evaluate the efficacy and safety of RoActemra/Actemra\n      (tocilizumab) as monotherapy or in combination with methotrexate or other non-biologic\n      DMARDs in patients with severe rheumatoid arthritis and an inadequate response to an\n      anti-tumour necrosis factor (anti-TNF) agent. Patients will receive RoActemra/Actemra 162 mg\n      subcutaneously weekly for 52 weeks."
        }, 
        "brief_title": "A Study of RoActemra/Actemra (Tocilizumab) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Patients With Severe Rheumatoid Arthritis and an Inadequate Response to an Anti-Tumour Necrosis Factor (Anti-TNF) Agent.", 
        "completion_date": {
            "#text": "September 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Rheumatoid Arthritis", 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Arthritis, Rheumatoid"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult patients, >/= 18 years of age\n\n          -  Active rheumatoid arthritis according to the revised (1987) ACR criteria or EULAR/ACR\n             (2010) criteria\n\n          -  Currently being treated with their first anti-TNF agent (in monotherapy or in\n             combination with MTX or other non-biologic DMARDs) and have not achieved an adequate\n             response to treatment at 24 weeks or after a minimum of 12 weeks therapy if permitted\n             by the local guidance, defined as DAS28 score improvement of less than 1.2 or having\n             achieved DAS28 score improvement of 1.2 but not low disease activity (current\n             DAS28-ESR above 3.2)\n\n          -  No previous exposure to RoActemra/Actemra (tocilizumab)\n\n          -  Oral corticosteroids (</= 10 mg/day prednisone or equivalent) and non-steroidal\n             anti-inflammatory drugs (NSAIDs; up to recommended dose) are permitted if on stable\n             dose regimen for >/= 4 weeks prior to baseline\n\n          -  Permitted non-biologic DMARDs are allowed if on stable dose for at least 4 weeks\n             prior to baseline\n\n          -  Receiving treatment on an outpatient basis, not including RoActemra/Actemra\n\n          -  Females of childbearing potential and males with female partners of childbearing\n             potential must agree to use reliable means of contraception as defined by protocol\n             during the study and for at least 3 months following the last dose of\n             RoActemra/Actemra\n\n        Exclusion Criteria:\n\n          -  Major surgery (including joint surgery) within 8 weeks prior to screening or planned\n             major surgery within 6 months following baseline\n\n          -  Rheumatic autoimmune disease other than rheumatoid arthritis (RA)\n\n          -  Functional Class IV as defined by the ACR Classification of Functional Status in\n             Rheumatoid Arthritis\n\n          -  Diagnosis of juvenile idiopathic arthritis or juvenile RA and/or RA before the age of\n             16\n\n          -  Prior history of or current inflammatory joint disease other than RA\n\n          -  Exposure to tocilizumab either intravenous or SC at any time prior to baseline\n\n          -  Treatment with any investigational agent within 4 weeks (or 5 half-lives of the\n             investigational drug, whichever is longer) of screening\n\n          -  Intra-articular or parenteral corticosteroids within 4 weeks prior to baseline\n\n          -  History of severe allergic or anaphylactic reactions to human, humanized or murine\n             monoclonal antibodies\n\n          -  Known active current or history of recurrent infections\n\n          -  Major episode of infection requiring hospitalization or treatment with IV antibiotics\n             within 4 weeks of screening or oral antibiotics within 2 weeks of screening\n\n          -  Active TB requiring treatment within the previous 3 years\n\n          -  Positive for hepatitis B or hepatitis C virus infection\n\n          -  Primary or secondary immunodeficiency (history of or currently active)\n\n          -  Pregnant or lactating women\n\n          -  Inadequate hematologic, renal or liver function"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "160", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 24, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02046603", 
            "org_study_id": "ML28641", 
            "secondary_id": "2013-000054-22"
        }, 
        "intervention": [
            {
                "arm_group_label": "RoActemra/Actemra", 
                "description": "162 mg SC weekly, 52 weeks", 
                "intervention_name": "tocilizumab [RoActemra/Actemra]", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "RoActemra/Actemra", 
                "description": "non-biologic disease-modifying antirheumatic drugs, up to recommended dose allowed", 
                "intervention_name": "DMARDs", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "RoActemra/Actemra", 
                "description": "</= 10 mg/day prednisone or equivalent allowed", 
                "intervention_name": "corticosteroids", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Antirheumatic Agents", 
                "Methotrexate"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "May 26, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Aberdeen", 
                        "country": "United Kingdom", 
                        "zip": "AB9 2ZB"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bournemouth", 
                        "country": "United Kingdom", 
                        "zip": "BH23 2JX"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brighton", 
                        "country": "United Kingdom", 
                        "zip": "BN2 5BE"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Burton on Trent", 
                        "country": "United Kingdom", 
                        "zip": "DE13 0RB"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bury St Edmonds", 
                        "country": "United Kingdom", 
                        "zip": "IP33 2QZ"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cannock", 
                        "country": "United Kingdom", 
                        "zip": "WS11 5XY"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cardiff", 
                        "country": "United Kingdom", 
                        "zip": "CF14 4XW"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chelmsford", 
                        "country": "United Kingdom", 
                        "zip": "CM1 7ET"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chester", 
                        "country": "United Kingdom", 
                        "zip": "CH2 1UL"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dewsbury", 
                        "country": "United Kingdom", 
                        "zip": "WF13 4HS"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dudley", 
                        "country": "United Kingdom", 
                        "zip": "DY1 2HQ"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dundee", 
                        "country": "United Kingdom", 
                        "zip": "DD12 9SY"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edinburgh", 
                        "country": "United Kingdom", 
                        "zip": "EH4 2XU"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Glasgow", 
                        "country": "United Kingdom", 
                        "zip": "G12 0YN"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Grimsby", 
                        "country": "United Kingdom", 
                        "zip": "DN33 2BA"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Harlow", 
                        "country": "United Kingdom", 
                        "zip": "CM20 1QX"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Harrow", 
                        "country": "United Kingdom", 
                        "zip": "HA1 3UJ"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hemel Hempstead", 
                        "country": "United Kingdom", 
                        "zip": "HP2 4AD"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hull", 
                        "country": "United Kingdom", 
                        "zip": "HU3 3JZ"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Llandudno", 
                        "country": "United Kingdom", 
                        "zip": "LL30 1LB"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "E11 1NR"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "NW3 2QG"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "zip": "W6 8RF"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Maidstone", 
                        "country": "United Kingdom", 
                        "zip": "ME16 9QQ"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Manchester", 
                        "country": "United Kingdom", 
                        "zip": "M23 9QZ"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newcastle Upon Tyne", 
                        "country": "United Kingdom", 
                        "zip": "NE7 7DN"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "North Shields", 
                        "country": "United Kingdom", 
                        "zip": "NE29 8NH"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Norwich", 
                        "country": "United Kingdom", 
                        "zip": "NR4 7UY"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oldham", 
                        "country": "United Kingdom", 
                        "zip": "OL1 1NL"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Solihull", 
                        "country": "United Kingdom", 
                        "zip": "B91 2JL"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stoke-on-trent", 
                        "country": "United Kingdom", 
                        "zip": "ST6 7AG"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Swindon", 
                        "country": "United Kingdom", 
                        "zip": "SN3 6BB"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Truro", 
                        "country": "United Kingdom", 
                        "zip": "TR1 3LJ"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Warrington", 
                        "country": "United Kingdom", 
                        "zip": "WA5 1QG"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wishaw", 
                        "country": "United Kingdom", 
                        "zip": "ML2 0DP"
                    }
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "1", 
        "official_title": "Open-label, Phase IIIb Study to Evaluate the Efficacy and Safety of Subcutaneous (SC) Tocilizumab Monotherapy or Combination Therapy With Methotrexate (MTX) or Other Non-biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) in Patients With Severe Rheumatoid Arthritis (RA) Who Are Being Treated With an Anti-tumour Necrosis Factor (Anti-TNF) Agent and That Have Not Achieved an Adequate Response to Treatment", 
        "overall_contact": {
            "email": "global.rochegenentechtrials@roche.com", 
            "last_name": "Reference Study ID Number: ML28641 www.roche.com/about_roche/roche_worldwide.htm", 
            "phone": "888-662-6728 (U.S. Only)"
        }, 
        "overall_official": {
            "affiliation": "Hoffmann-La Roche", 
            "last_name": "Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United Kingdom: Medicines and Healthcare Products Regulatory Agency"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "September 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change in disease activity DAS28-ESR score", 
            "safety_issue": "No", 
            "time_frame": "from baseline to Week 52"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02046603"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "American College of Rheumatology (ACR) response scores", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }, 
            {
                "measure": "Response according to EULAR criteria", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }, 
            {
                "measure": "Change in SDAI/CDAI", 
                "safety_issue": "No", 
                "time_frame": "from baseline to Week 52"
            }, 
            {
                "measure": "Change in tender/swollen joint count (TJC/SJC)", 
                "safety_issue": "No", 
                "time_frame": "from baseline to Week 52"
            }, 
            {
                "measure": "Proportion of patients with DMARD/corticosteroid dose reduction/discontinuation", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }, 
            {
                "measure": "Patient reported outcomes: Patient Global Assessment of disease activity and Patient Pain VAS, HAQ-Disability Index, FACIT-F, compliance diary, adherence to methotrexate questionnaire", 
                "safety_issue": "No", 
                "time_frame": "52 weeks"
            }, 
            {
                "measure": "Safety: Incidence of adverse events", 
                "safety_issue": "No", 
                "time_frame": "60 weeks"
            }, 
            {
                "measure": "Immunogenicity: Incidence of anti-tocilizumab antibodies", 
                "safety_issue": "No", 
                "time_frame": "60 weeks"
            }
        ], 
        "source": "Hoffmann-La Roche", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hoffmann-La Roche", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}